Author Information
Alexandra Calmy is affiliated with the Division of Infectious Diseases at the University Hospital Geneva in Geneva, Switzerland. She is a prominent researcher in the field of infectious diseases, with a particular focus on HIV and related complications. Her work is integral to understanding the complexities of HIV treatment and management, as well as the broader implications for public health and clinical practices.Research Contributions
Dr. Alexandra Calmy has made significant contributions to the field of infectious diseases, with a special emphasis on HIV. Her research covers a wide range of topics including anticholinergic medication use in elderly people living with HIV, women's participation in HIV clinical research, the long-term effects of medications like evolocumab in HIV patients with dyslipidemia, and the intersection of HIV with other health conditions such as Type 2 Diabetes Mellitus. Her work on the highly virulent variant of HIV-1 circulating in the Netherlands, as well as her insights into the menopause transition in women with HIV, underscore her comprehensive approach to understanding HIV in various contexts. Additionally, Dr. Calmy has contributed to research on COVID-19, particularly examining the effects of dexamethasone in severe hypoxemia cases and the impact of SARS-CoV-2 vaccination on HIV-infected individuals.Aliases
Dr. Alexandra Calmy is known by several aliases, including Alexandra. Calmy, A Calmy, A. Calmy, Alexandra L Calmy, and Alexandra Calmy. These variations can be found across different publications and databases, reflecting common practices in academic publishing.Publication and Citation Metrics
| Metric |
Value |
| Total Citation Count |
15,922 |
| H-index |
65 |
| Total Paper Count |
501 |
